cannabis policy Related News
CBD content has no bearing on cannabis safety
The CBD content of cannabis has no effect on the drug’s safety, according to researchers from the Institute of Psychiatry, Psychology & Neuroscience at...
Opioids versus medicinal cannabis for chronic pain
The topic of opioids versus medicinal cannabis for chronic pain is widely discussed with researchers and medical professionals taking a firm stance. Here, medicinal...
US states with legal cannabis have higher underage recreational use
An investigation performed by the University of California San Diego has discovered that underage recreational cannabis use is more prevalent in US states with...
Banking and finance in the medicinal cannabis industry
Mitch Ratajkoski of LeafCann explores how the banking industry is limiting operations and growth for companies in the medicinal cannabis industry.
Banking has become an...
Black market cannabis sales remain high despite legalisation
Research from the University of Waterloo has identified that despite being legalised in various parts of North America, black market cannabis sales are still...
How LED technology can accelerate Germany’s recreational cannabis market
Timo Bongartz, general manager, EMEA, Fluence discusses how LED technology could benefit recreational cannabis cultivation in Germany.
Green is the new gold. Four hundred tonnes of...
Growing the UK medical cannabis sector through exportation
Jonathan Hodgson, the CEO of Rokshaw Laboratories, and Pierre van Weperen, the CEO of Grow Pharma ltd., outline the vast benefits of exporting medical...
Recreational cannabis access reduces prescription drug use in the US
A new study in the US has revealed that legalising recreational cannabis has significantly reduced the use of prescription medications.
Performed by a team of...
Study reveals dangers of driving after smoking cannabis
A comprehensive, two-year randomised trial has unveiled the effects of driving after smoking cannabis, illustrating the risks of getting behind the wheel under the...
New report calls for UK to capitalise on potential £1.2bn medical cannabis industry
A new report by drug policy reform advocacy group Volteface has revealed the UK is missing out on a potential £1.2bn medical cannabis industry...
The current landscape of medical cannabis in the United States
Dr Leigh Vinocur, Chief Medical Officer of cannabis consulting company Ananda Medical Practice and member of the Society of Cannabis Clinicians, discusses the state...
Association for the Cannabinoid Industry to expand EU Offering
The Association for the Cannabinoid Industry (ACI) has announced the opening of a new Brussels office as they expand their membership offering into the...
Campaigner requests meeting with PM to discuss NHS medical cannabis
Medical cannabis campaigner Hannah Deacon has delivered a letter to UK Prime Minister, Boris Johnson, requesting a meeting to discuss medical cannabis access on...
Medical cannabis campaigners visit Westminster
Medical cannabis campaigners visited Westminster as part of a walk from Belfast to London to raise funds for the UK’s most vulnerable, chronically ill...
Whither the winds of the European cannabis industry post-pandemic?
The European Cannabis Association is setting its sights on harmonising the cannabis regulatory environment across the continent.
The COVID-19 pandemic is a generation- if not...
Towards a UK cannabis industry
Health Europa Quarterly (HEQ) speaks with Mike Barnes of Maple Tree Consultants and Ricardo Geada of Mackrell Solicitors about the need for a legal...
New council body launched to demand robust UK cannabis industry
A collective of organisations, businesses, and working groups have united to launch The Cannabis Industry Council – the first representative cannabis body dedicated to...
Evidence, policy and regulation in medical cannabis
The Centre for Medicinal Cannabis hosted a crucial summit in April aimed at shaping the future of the UK’s medical cannabis sector.
On Thursday 15...
Access to medicinal cannabis treatments in Europe
In this article, Sita Schubert, General Secretary of the European Medicinal Cannabis Association, discusses the need to get better access to medicinal cannabis treatments...
Examining the future of Europe’s medical cannabis treatments
Sita Schubert, the General Secretary of the European Medicinal Cannabis Association, discusses the future of medical cannabis treatments in Europe, looking at how they...
